---
category: listing
circular_id: b1bdd3120f97617d
date: '2025-08-14'
description: BSE announces the listing of equity shares of STAR IMAGING AND PATH LAB
  LIMITED on the SME segment with scrip code 544482.
draft: false
guid: https://www.bseindia.com/markets/MarketInfo/DispNoticesNCirculars.aspx?Noticeid={C144469F-93AE-4258-9FD1-2EADD248F983}&noticeno=20250814-8&dt=08/14/2025&icount=8&totcount=59&flag=0
impact: medium
impact_ranking: medium
importance_ranking: medium
justification: New equity listing on SME segment - standard corporate action with
  moderate market relevance
pdf_url: https://www.bseindia.com/markets/MarketInfo/DownloadAttach.aspx?id=20250814-8&attachedId=
processing:
  attempts: 1
  content_hash: c6113615ad21beaf
  processed_at: '2025-08-14T15:38:09.308266'
  processor_version: '2.0'
  stage: completed
  status: published
published_date: '2025-08-14T08:35:14+00:00'
rss_url: https://www.bseindia.com/markets/MarketInfo/DispNoticesNCirculars.aspx?Noticeid={C144469F-93AE-4258-9FD1-2EADD248F983}&noticeno=20250814-8&dt=08/14/2025&icount=8&totcount=59&flag=0
severity: medium
source: bse
stocks:
- STARIMAGIN
tags:
- listing
- equity-shares
- sme
- star-imaging-path-lab
title: Listing of Equity Shares of STAR IMAGING AND PATH LAB LIMITED
---

## Summary

BSE Limited has announced the listing of equity shares of STAR IMAGING AND PATH LAB LIMITED on the Exchange's SME segment. The company will trade under scrip code 544482 and symbol STARIMAGIN with ISIN INE0YG001013.

## Key Points

- Company Name: STAR IMAGING AND PATH LAB LIMITED
- Scrip Code: 544482
- Trading Symbol: STARIMAGIN
- ISIN: INE0YG001013
- Segment: SME (Small and Medium Enterprises)
- Listing status: Approved for listing and trading

## Regulatory Changes

No regulatory changes - this is a standard new listing announcement.

## Compliance Requirements

- Trading members are informed about the new listing
- Company must comply with SME segment listing requirements
- Standard post-listing compliance obligations will apply

## Important Dates

- Notice Date: August 14, 2025
- Listing Date: To be announced in separate notice
- Trading commencement: To be announced in separate notice

## Impact Assessment

This is a routine new listing on the SME segment. The impact is moderate as it adds a new trading instrument for investors interested in small and medium enterprises in the healthcare/diagnostics sector. The exact listing date and trading details will be communicated separately by BSE.